2025
SJR Q1
JCR Q1 · 6,5
OA
13 matched articles
SCIE
Journal detail
Molecular Therapy Nucleic Acids
- Publisher
- Cell Press
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
21622531
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 2,068
- Quartile Q1
- H-Index 113
- Cites/doc 5,38
- Docs (3y) 852
- Cites (3y) 4.762
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 6,5
- 5Y JIF 6,2
- JCI 1,4
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Drug Discovery Q1
- Molecular Medicine Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Medicine, Research & Experimental
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 2,068 | 6,5 | 6,2 | 1,4 | Q1 | 113 |
| 2024 | Q1 | Q1 | 2,046 | 6,1 | 6,3 | 1,58 | Q1 | 104 |
| 2023 | Q1 | Q1 | 1,849 | 6,5 | 6,7 | 1,83 | Q1 | 104 |
| 2022 | Q1 | Q1 | 1,947 | 8,8 | 8,4 | 2,08 | Q1 | 104 |
| 2021 | Q1 | Q1 | 1,852 | 10,2 | 9 | 2,22 | Q1 | 104 |
| 2020 | Q1 | Q1 | 2,208 | 8,9 | 8,3 | 2,29 | Q1 | 104 |
| 2019 | Q1 | Q1 | 2,089 | 7 | 6,8 | 2,29 | Q1 | 104 |
| 2018 | — | Q1 | — | 5,9 | 6 | 2,19 | Q1 | — |
| 2017 | Q1 | Q1 | 2,523 | 5,7 | 5,9 | 2,2 | Q1 | 104 |
| 2016 | Q1 | Q1 | 2,795 | 6,4 | 5,8 | — | — | 104 |
| 2015 | Q1 | Q1 | 2,308 | 5 | 5,2 | — | — | 104 |
| 2014 | Q1 | Q1 | 1,727 | 4,5 | 4,5 | — | — | 104 |
| 2013 | Q1 | — | 1,062 | — | — | — | — | 104 |
| 2012 | — | — | — | — | — | — | — | 104 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 37/191 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 34/195 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 25/189 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 18/136 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 16/139 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 13/140 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 13/139 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 15/136 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 14/133 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 10/128 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 15/124 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 19/123 |